Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody

Catalog No. ABIN7598064

This Human Monoclonal antibody specifically detects CTLA-4 (Tremelimumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant CTLA-4 (Tremelimumab Biosimilar) antibody (ABIN7598064)

Target: CTLA-4 (Tremelimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CTLA-4 (Tremelimumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CTLA-4 (Tremelimumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Tremelimumab Biosimilar Antibody

Specificity: CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CTLA-4 (Tremelimumab Biosimilar)

Target: CTLA-4 (Tremelimumab Biosimilar)

Alternative Name: Tremelimumab Biosimilar

Target Type: Biosimilar

Background: CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

UniProt: P16410

CAS-No: 745013-59-6